Clinical Trial

Effectiveness and Tolerability of Eqwilate in Real-life Conditions

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
MOdalities of use, effectiveNEss and TOlerability of Eqwilate® a balanced combInatiON of VWF and FVIII in von WillEbrand patients in real-life conditions: the ONE-TO-ONE study
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2019-09-25; most recent amendment 2026-07-15.
Status change: Recruiting → Active, Not Recruiting 2025-04-15
Status change: Not Yet Recruiting → Recruiting 2019-12-31
Trial Details
NCT Number NCT04106908
Lead Sponsor Octapharma
Conditions VWD - Von Willebrand's Disease
Enrollment 38 participants
Start Date 2019-11-27
Primary Completion 2024-05-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2026-07-16